Trial Information
Tissue and Serum Collection From Colorectal Cancer Patients
Inclusion Criteria:
- Patients must be undergoing surgery for resection of their primary tumor, resection
of hepatic metastases, or hepatic artery catheter and pump implant for unresectable
hepatic metastases.
- For and tumor specimen removed at surgery ,the lesion must be large enough to allow
for routine pathological analysis, with excision from residual otherwise discarded
material for the tumor bank.
Exclusion Criteria:
N/A
Type of Study:
Observational
Study Design:
Observational Model: Case-Only, Time Perspective: Prospective
Outcome Measure:
establish a serum and tissue bank
Outcome Time Frame:
5 years
Safety Issue:
No
Principal Investigator
Philip Paty, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Memorial Sloan-Kettering Cancer Center
Authority:
United States: Food and Drug Administration
Study ID:
89-006
NCT ID:
NCT00579891
Start Date:
March 1989
Completion Date:
December 2013
Related Keywords:
- Colorectal Cancer
- colorectal cancer
- tissue collection
- Colorectal Neoplasms
Name | Location |
Memorial Sloan-Kettering Cancer Center |
New York, New York 10021 |